Siegfried: Mandatory Convertible Bond Completely Converted
For further information:
Peter Gehler, Head Corporate Center
peter.gehler@siegfried.ch
Tel. +41 (0)62 746 11 48
Mobile +41 (079) 416 41 16
Fax +41 (0)62 746 11 03
Siegfried Holding AG
Untere Brühlstrasse 4
CH-4800 Zofingen
Tel. +41 (0)62 746 11 11
Fax +41 (0)62 746 11 03
www.siegfried.ch
About Siegfried
Active in Life Science markets, the Siegfried Group is a global manufacturer of pharmaceutical products with produc- tion facilities located in Switzerland, Malta and the USA. At the end of 2010, Siegfried employed approximately 700 employees and achieved annual sales of CHF 314 million. Siegfried Holding AG is listed on the Swiss Exchange in Zurich (SIX: SFZN).
Siegfried is active in both the primary and secondary production of drugs. The company develops and manufactures active pharmaceutical ingredients for the research-based pharmaceutical industry as well as the corresponding inter- mediate steps and standard products, and provides development and production services for drugs in finished dos- age forms.